Singapore: AstraZeneca unveils plans to build ADC manufacturing facility
UK-based AstraZeneca, a global biopharmaceutical company, has announced plans to build a US$1.5bn manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its...
View ArticleFinland: Donze takes up CEO role at Bioretec
Bioretec, a medical device company pioneering the application of biodegradable orthopedic implants, has appointed Alan Donze as CEO. Donze began his career in banking, serving as the VP of Commercial...
View ArticleUK: Pheon completes US$120m Series B to fund ADC pipeline development
Pheon Therapeutics, an Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, has completed a US$120m Series B financing to fund the...
View ArticleGermany: Aurelius-backed aesco solutions acquires seleon from D11Z. Ventures
Germany based aesco solutions, a CDMO for medical device companies has acquired seleon from D11Z. Ventures (formerly Zukunftsfonds Heilbronn). Founded in 1998, seleon is a Germany-based development,...
View ArticleUK: Compass Recruitment Solutions acquires Carter Schwartz to form Compass...
Compass Recruitment Solutions (CRS) has made the strategic acquisition of UK executive search boutique Carter Schwartz, merging its executive search business, Compass Executives, to form Compass Carter...
View ArticleBelgium: WorxInvest becomes reference shareholder in GIMV
The sale of Gimv shares by the Vlaamse Participatiemaatschappij (VPM) to the diversified investment company WorxInvest has been finalised following receipt of all regulatory approvals. Belgium-based...
View ArticleIndia: KKR takes stake in Infinx alongside existing shareholder Norwest...
Leading global investment firm, KKR, has taken a significant minority stake in Infinx Services, an AI-driven healthcare revenue cycle solutions provider. Norwest Venture Partners, an existing...
View ArticleAustralia: Lunit completes acquisition of Volpara
Korea-based Lunit, a global provider of AI-powered solutions for cancer diagnostics and therapeutics, has completed its acquisition of Volpara Health Technologies, an Australia-based provider of...
View ArticleSwitzerland: SixPeaks Bio emerges from stealth with US$110m in fundinig
SixPeaks Bio has emerged from stealth with a pipeline of therapies for healthy weight loss and US$110m in funding. The company has secured US$30m in Series A financing led by […]
View ArticleUK: New care home for Gravesend following land sale
Property adviser, Christie & Co, has announced the sale of a development site in Gravesend, Kent, which benefits from planning permission for a 75-bedroom care home. The scheme, delivered by […]
View ArticleItaly: Gerresheimer to acquire Bormioli Pharma Group
Gerresheimer Glas, an indirect subsidiary of global partner to the pharma, biotech, and cosmetics industries Gerresheimer, is to acquire Blitz LuxCo, the holding company of the Bormioli Pharma Group,...
View ArticleGermany: Merck KGaA to acquire Mirus Bio for US$600m
Merck KGaA is to acquire Mirus Bio, a provider of transfection products for the biopharmaceutical and research industries, from Gamma Biosciences, a life sciences platform established by KKR to address...
View ArticleUK: Bicycle Therapeutics raises US$555m via PIPE
Nasdaq-listed Bicycle Therapeutics, a UK-headquartered pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology,...
View ArticleItaly: XGEN announces first fund with €160m in subscriptions
XGEN Venture – a newly formed Venture Capital firm – has announced its first fund, XGEN Venture Life Science Fund, with €160m (US$173m) in subscriptions. Launched in December 2022, the […]
View ArticleFrance: Bryan Garnier announces series of promotions in healthcare
Bryan Garnier, a European growth investment bank, has announced a series of promotions, bolstering its leadership team to address the issue of volatile markets. “By investing in our teams, we […]
View ArticleUK: Medical Properties Trusts completes £631m loan backed by UK portfolio
Medical Properties Trust (MPT), a US based hospital REIT, has completed a new £631m (US$800m) non-recourse, non-amortizing secured financing backed by certain properties in its UK portfolio. The...
View ArticleKSA: TVM Capital Healthcare closes Afiyah Fund at US$250m
TVM Capital Healthcare, an international healthcare expansion and growth capital investor, has closed the TVM Healthcare Afiyah Fund at approximately US$250m, its second pool of capital in the Middle...
View ArticleSweden: Calliditas board accepts Asahi Kasei offer of SEK11.8bn
Japan-based Asahi Kasei Corp has offered to acquire the shares of Sweden-based Calliditas Therapeutics. Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas, which are listed […]
View ArticleSwitzerland: Johnson & Johnson to obtain rights to develop Numab’s NM26 for...
Numab Therapeutics, a clinical stage biotechnology company, is selling Yellow Jersey Therapeutics (YJT), a wholly-owned subsidiary of Numab, to US-based multinational Johnson & Johnson for...
View ArticleGermany: Sunrise Medical plans listing on the Frankfurt Stock Exchange
Sunrise Medical, a global developer of assistive mobility solutions, has announced plans to list on the regulated market (Prime Standard) of the Frankfurt Stock Exchange in the summer of 2024, […]
View Article